Overactive Bladder - Results from #2140

An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: Results of the STOP study - Abstract July 30, 2012

The prevalence of probable overactive bladder, associated risk factors and its effect on quality of life among Turkish midwifery students - Abstract July 27, 2012

Repeated injection of botulinum toxin a in patients with neurogenic bladder: Our experience - Abstract July 26, 2012

Treatment of overactive bladder: What is on the horizon? - Abstract July 25, 2012

Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study - Abstract July 24, 2012

Impact of overactive bladder on work productivity - Abstract July 23, 2012

A survey on the effect of anticholinergic therapy on post-void dribbling - Abstract July 23, 2012

Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS - Abstract July 20, 2012

Quality of life in patients with overactive bladder: Validation and psychometric properties of the spanish overactive bladder questionnaire-short form - Abstract July 19, 2012

A predictive factor in overactive bladder symptoms improvement after combined anterior vaginal wall prolapse repair: a pilot study - Abstract July 18, 2012

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity - Abstract July 17, 2012

Stand up urgency: Is this symptom related to a urethral mechanism? - Abstract July 16, 2012

What to do if percutaneous tibial nerve stimulation (PTNS) works? A pilot study on home-based transcutaneous tibial nerve stimulation - Abstract July 13, 2012

Changes in urinary nerve growth factor and prostaglandin E(2) in women with overactive bladder after anticholinergics - Abstract July 12, 2012

Antimuscarinic treatment in overactive bladder: Special considerations in elderly patients - Abstract July 11, 2012

Patient-reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms - Abstract July 10, 2012

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-Adrenoceptor agonist solabegron for overactive bladder - Abstract July 10, 2012

Treatment of overactive bladder symptoms beyond antimuscarinics: Current and Future Therapies - Abstract July 5, 2012

The association between overactive bladder and fibromyalgia syndrome: A community survey - Abstract July 4, 2012

Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study - Abstract July 3, 2012

Page 108 of 122